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Three-dimensional dosimetry imaging of I-125 plaque for eye cancer treatment
Abstract
Treatment of ocular cancers using eye plaque brachytherapy is now an established medical procedure.
However, current QA for these eye plaques is quite rudimentary, limiting the opportunities for precise pretumour plaque customisation. This paper proposes and experimentally validates a new technique for
imaging of eye plaque dose distributions using a high-resolution pixelated silicon detector. Results are
presented demonstrating the 2D and 3D isodose surfaces produced using experimental data collected
using this method.
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Abstract
Treatment of ocular cancers using eye plaque brachytherapy is now an established medical procedure. However, current QA
for these eye plaques is quite rudimentary, limiting the opportunities for precise per-tumour plaque customisation. This paper
proposes and experimentally validates a new technique for imaging of eye plaque dose distributions using a high-resolution
pixelated silicon detector. Results are presented demonstrating the 2D and 3D isodose surfaces produced using experimental
data collected using this method. © 2001 Elsevier Science. All rights reserved
Keywords: brachytherapy; ocular cancer; dosimetric imaging; pixelated detector

1. Introduction
Melanoma and squamous cell carcinoma are the
most prevalent ocular malignancies in adults [1].
Disease morbidity and cost to the community is
significant with almost 50% of patients losing vision
or the eye due to the disease and/or the treatment
[2,3]. Ocular melanoma is typically treated by
resection of the surgical mass or for progressed
tumours, via enucleation [4]. However, radiotherapy
remains the most widely used treatment for posterior
uveal melanoma, which carries a serious prognosis,

especially if the tumour is medium or large in size
[4]. Brachytherapy using radioactive eye plaques is
the preferred method of treatment for patients with
ocular malignancies.
Eye brachytherapy involves the surgical insertion
of a radioactive plaque behind the tumour residing
within the eye of the patient. At present, the most
popular eye plaques used for treating ocular cancers
incorporate I-125 seeds or are uniformly coated with
a radioactive material such as Ru106/ Rh106 [5].
There are currently no procedures with the ability
to provide quality assurance (QA) for customised
plaques, taking into account factors such as tumour
shape, location, and proximity to vital structures,
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such as the optic nerve and macula which have been
shown to receive up to 85% and 58% respectively of
the prescribed dose during treatment[6]. This can
result in optic neuropathy and macular degeneracy
[7]. Furthermore, when the primary treatment fails to
completely eradicate the tumour, the prognosis in
terms of eye and sight preservation as well as
survival becomes significantly reduced [4]. Overall,
the failure rate after eye plaque brachytherapy is
reported to be up to 10% and is a result of
inaccuracies in dosage as well as the surgical
placement of plaques [1].
Experimental dosimetry in ocular radiotherapy,
where tumours are small and can be close to critical
structures such as the optical nerve, demands high
spatial resolution dosimetry and high detector
dynamic range due to the steep dose gradients
involved. A new approach is required to provide real
time, high spatial resolution, low dose rate dosimetry
for eye plaque QA.
QA of Ru-106 plaques using single fibre optic
plastic scintillator dosimeters has previously been
reported [8, 9]. However, this requires a slow and
complex scanning assembly to obtain 2D dose
distributions and is limited in spatial resolution due
by the size of the device (1.0x0.5mm) [8, 9].
Spectroscopic dosimetry, based on silicon radiation
detectors, has been successfully used for point
dosimetry in low dose rate brachytherapy utilising I125 seeds [10]. A pixelated, 2D array of such
detectors, used in spectroscopy mode, is well suited
for QA of eye plaque dosimetry. Silicon pixelated
detectors such as the Medipix2 [11] and Timepix
have been successfully used in radiography,
neutronography, and micro-tomography [12] and are
currently being investigated for eye plaque dosimetry
at CMRP. These devices consist of an array of
individual detectors (55x55µm pixels) [12]. Silicon
pixelated detectors operating in spectroscopy mode
can generate dosimetric images when placed below
the treatment plaque within a phantom. The
dosimetric images can be used to generate threedimensional dose functions with a high spatial
resolution providing the desired dosimetric QA of the
treatment prior to the procedure.

2. Method
The silicon pixelated detector, Medipix2, was used
to obtain two dimensional dose distributions in
several planes within a segmented 24mm diameter
Perspex eye phantom. A 15mm ROPES stainless
steel eye plaque, loaded with Oncura 6711 I-125
based seeds, was attached to the phantom. Medipix2
calibration was performed on the central axis of the
phantom with a single I-125 seed and the TG-43
protocol. Absolute calibration was conducted with
one seed at depth 5mm. These results were compared
with values predicted by the TG-43 treatment
planning software (TPS) developed at CMRP to
verify the dosimetry setup.
Two seed configurations of the eye plaque were
tested; an asymmetric 5 seed distribution, and a full
10 seed distribution. Measurements at various planar
angles were performed for the two seed
configurations. With the plaque mounted on the top
of the phantom, 2D dosimetric images were obtained
using the Medipix2 at depths of 5, 10, 15, 20 and
25mm from the surface of the eye phantom closest to
the plaque and calibrated using the previous depthdose measurements. The 25 mm measurement was
repeated with the plaque mounted at angles of 18º,
45º, 75º, and 90º normal to Medipix2 plane. The
resulting orthogonal and oblique 2D dosimetric
images, with spatial resolution of 55um were used for
reconstruction of 2D isodose lines and 3D isodose
surfaces.

3. Results
The relative depth response of the Medipix2 was
in agreement with the TG-43 depth dose distribution
of a single seed to within 2%. Good conformity was
achieved with the depth dose predicted by the TPS
for this seed configuration of eye plaque.
The depth planes measured by the detector can be
seen in the left image of Figure 1 as a stack of 2D
dosimetric images. The right hand image shows the
calibrated isodose surfaces generated from the 2D
dosimetric images. The 3D reconstruction of the
series of planar angle dosimetric images can be seen
in Figure 2.
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entire eye. This research provides significant
evidence to suggest the feasibility of the
customisation of eye plaques to optimise
brachytherapy treatment of patients with eye
melanomas as well as offering an accurate and real
time QA system for treatment planning verification.
An improved plaque-sensor distance control
method is currently being evaluated at CMRP. The
process involves the use of a linear actuator to control
the plaque-detector distance within a liquid
environment.

Figure 1: Two dimensional measurements used to create isodose
surfaces of plaque loaded with five I-125 seeds
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Figure 2: Reconstructed image using a number of two dimensional
planar angles for 5 seeds plaque.

4. Discussion
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imaging for eye plaque QA will support the
development of new medical procedures for the
realisation of patient-specific plaques with the best
customised dose distribution for each unique tumour.
With a data acquisition time of just seconds and a
high spatial resolution, this system overcomes many
of the current limitations in dosimetry for clinical
treatment, providing 3D dose imaging through the
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